49.22
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
Is it time to cut losses on Supernus Pharmaceuticals Inc.2025 Macro Impact & AI Driven Stock Movement Reports - newser.com
Is Supernus Pharmaceuticals Inc. stock near bottom after declineWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Why Supernus Pharmaceuticals Inc. stock remains undervaluedTrend Reversal & Precise Buy Zone Identification - newser.com
Supernus Pharmaceuticals Inc Stock Analysis and ForecastGlobal Trade Effects & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Supernus Pharmaceuticals Inc. (SUPN) Stock Price | Live Quotes & Charts | NSD - StocksToTrade
Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should Know - Yahoo Finance
Published on: 2025-10-13 06:52:20 - newser.com
What MACD signals say about Supernus Pharmaceuticals Inc.Wall Street Watch & Daily Stock Trend Watchlist - newser.com
Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines - TradingView
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Did Piper Sandler’s Upgrade on Onapgo Just Shift Supernus Pharmaceuticals' (SUPN) Investment Narrative? - Sahm
Supernus CEO Khattar sells $3m in shares By Investing.com - Investing.com Canada
Insider Sell Alert: NEWHALL CHARLES W III Sells 25,000 Shares of Supernus Pharmaceuticals Inc (SUPN) - GuruFocus
Supernus Pharmaceuticals Executives Sell Shares - TradingView
SUPN Crosses Above Average Analyst Target - Nasdaq
Supernus Pharmaceuticals Shares Rise After Piper Sandler Upgrade - MarketScreener
Supernus Pharmaceuticals: A Rising Pharma Contender? - StocksToTrade
Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know - Yahoo Finance
SUPN: Piper Sandler Raises Price Target to $65 and Upgrades Rati - GuruFocus
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $65 From $40 - MarketScreener
Can Supernus Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com
How Supernus Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-09 05:01:01 - newser.com
Supernus (SUPN) Receives Upgraded Rating Amid Promising Product Outlook - GuruFocus
How to use Fibonacci retracement on Supernus Pharmaceuticals Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Supernus Pharmaceuticals (SUPN): Exploring Valuation After Three-Month Share Price Surge - Sahm
Is now a turning point for Supernus Pharmaceuticals Inc.July 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Supernus Pharmaceuticals Hits New 52-Week High of $49.66 - Markets Mojo
Will Supernus Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Weekly Top Performers Watchlists - newser.com
How geopolitical tensions affect Supernus Pharmaceuticals Inc. stockCPI Data & Comprehensive Market Scan Insights - newser.com
Why Supernus Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Using R and stats models for Supernus Pharmaceuticals Inc. forecasting2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
Is Supernus Pharmaceuticals Inc. stock poised for growthPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Is Supernus Pharmaceuticals Inc. stock cheap compared to fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Wall Street Zen Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Hold - Defense World
Smart tools for monitoring Supernus Pharmaceuticals Inc.’s price actionQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
Real time social sentiment graph for Supernus Pharmaceuticals Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com
Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by GAMMA Investing LLC - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):